3 Firms Guide Biopharma Co. ZyVersa's $109M SPAC Merger
Biopharmaceutical company ZyVersa Therapeutics Inc. entered into a $109 million merger agreement with blank-check company Larkspur Health Acquisition Corp. on Wednesday, with guidance from Lowenstein Sandler LLP, Manatt Phelps & Phillips LLP...To view the full article, register now.
Already a subscriber? Click here to view full article